Impact of add-back FSH on human and mouse prostate following gonadotropin ablation by GnRH antagonist treatment

OBJECTIVE: During androgen ablation in prostate cancer by the standard gonadotropin-releasing hormone (GnRH) agonist treatment, only luteinizing hormone (LH) is permanently suppressed while circulating follicle-stimulating hormone (FSH) rebounds. We explored direct prostatic effects of add-back FSH,...

Descripción completa

Detalles Bibliográficos
Autores principales: Deiktakis, Eleftherios E, Ieronymaki, Eleftheria, Zarén, Peter, Hagsund, Agnes, Wirestrand, Elin, Malm, Johan, Tsatsanis, Christos, Huhtaniemi, Ilpo T, Giwercman, Aleksander, Giwercman, Yvonne Lundberg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254324/
https://www.ncbi.nlm.nih.gov/pubmed/35575351
http://dx.doi.org/10.1530/EC-21-0639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254324/
https://www.ncbi.nlm.nih.gov/pubmed/35575351
http://dx.doi.org/10.1530/EC-21-0639

Ejemplares similares